Evidence map›Paper›PMID 28375515›Full record

ReviewThe Journal of infectious diseases2017

Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.

Edward Geisinger, Ralph R Isberg

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Influence of iron uptake systems on cefiderocol activity inAntimicrobial agents and chemotherapy · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Redefining Antimicrobial Resistance inInternational journal of molecular sciences · 2026
    Review
  9. Article
  10. Article
  11. Strain-specific persistence ofJournal of medical microbiology · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Molecular analysis of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Edward GeisingerHoward Hughes Medical Institute, and.
Ralph R IsbergHoward Hughes Medical Institute, and.
Tufts University · US

Funding

Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillanU01AI124302 · NIAID · BOSTON COLLEGE · PI BENTO, JOSE, COOPER, VAUGHN · 2016 to 2020
$10.2M
Type VI Protein Secretion in an Emerging Multidrug-Resistant PathogenF32AI098358 · NIAID · TUFTS UNIVERSITY BOSTON · PI GEISINGER, EDWARD · 2012 to 2014
$168k
NIAID NIH HHS F32 AI098358NIAID NIH HHS U01 AI124302
6 · The paper itself

Abstract

Diseases caused by antibiotic-resistant bacteria in hospitals are the outcome of complex relationships between several dynamic factors, including bacterial pathogenicity, the fitness costs of resistance in the human host, and selective forces resulting from interventions such as antibiotic therapy. The emergence and fate of mutations that drive antibiotic resistance are governed by these interactions. In this review, we will examine how different forms of antibiotic resistance modulate bacterial fitness and virulence potential, thus influencing the ability of pathogens to evolve in the context of nosocomial infections. We will focus on 3 important multidrug-resistant pathogens that are notoriously problematic in hospitals: Pseudomonas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus. An understanding of how antibiotic resistance mutations shape the pathobiology of multidrug-resistant infections has the potential to drive novel strategies that can control the development and spread of drug resistance.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-Lactam ResistanceCross InfectionDrug Resistance, Multiple, BacterialGene Expression Regulation, BacterialHumansMicrobial Sensitivity TestsMutationPorinsPseudomonas aeruginosaPseudomonas InfectionsAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesOprD protein, Pseudomonas aeruginosaPorinsVirulence FactorsAcinetobacter baumanniiantibiotic resistancefitnessPseudomonas aeruginosaStaphylococcus aureusvirulence

Identifiers

PMID28375515
PMCPMC5853982
OpenAlexW2598043550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.